Efficacy of Acute Inhalation of Nitric Oxide in Patients With Primary Pulmonary Hypertension Using Chronic Use of Continuous Epoprostenol Infusion-Reference-Cited by-同舟云学术

Efficacy of Acute Inhalation of Nitric Oxide in Patients With Primary Pulmonary Hypertension Using Chronic Use of Continuous Epoprostenol Infusion

Published:2005 Issue:3 Volume:69 Page:335-338
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Saji Kenya¹,Sakuma Masahito¹,Suzuki Jun¹,Takahashi Tohru¹,Demachi Jun¹,Nawata Jun¹,Kitamukai Osamu¹,Onoue Noriko¹,Sugimura Kouichiro¹,Tada Tomohiro¹,Fukui Shigefumi¹,Kagaya Yutaka¹,Watanabe Jun¹,Shirato Kunio¹

Affiliation:

1. Department of Cardiovascular Medicine, Tohoku University Graduated School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/69/3/69_3_335/_pdf

Reference30 articles.

1. Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

2. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

3. Novel Insertional Mutation in the Bone Morphogenetic Protein Receptor Type II Associated With Sporadic Primary Pulmonary Hypertension

4. Effects and Problems of Continuous Infusion of Epoprostenol for Patients with Primary Pulmonary Hypertension.

5. A combination of oral endothelin-areceptor antagonist and oral prostacyclinanalogue is superior to each drug alone inameliorating pulmonary hypertension in rats

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of inhaled nitric oxide with aerosolized prostacyclin or analogues for the postoperative management of pulmonary hypertension: a systematic review and meta-analysis;Annals of Medicine;2020-04-02

2. Comparison of Acute Hemodynamic Effects of Inhaled Nitric Oxide and Inhaled Epoprostenol in Patients with Pulmonary Hypertension;Pulmonary Circulation;2013-01

3. Treatment of Refractory Pulmonary Arterial Hypertension with Inhaled Epoprostenol in an Infant with Congenital Heart Disease;Congenital Heart Disease;2007-05

4. Beneficial Acute Effects of Rho-Kinase Inhibitor in Patients With Pulmonary Arterial Hypertension;Circulation Journal;2006

5. Bosentan Improved Syncope in a Hemodialysis Patient With Pulmonary Hypertension and Mild Aortic Stenosis;International Heart Journal;2006